Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2
1998 · Nature Medicine · 339 citations
https://doi.org/10.1038/nm0698-691
S
Steven Ledbetter
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
5.0K
Citations
34
h-index
50
i10-index
Steven Ledbetter is an academic researcher from MACOM (United States). The author has contributed to research in topics: Proteoglycans and glycosaminoglycans research & Cell Adhesion Molecules Research & Musicology and Musical Analysis. The author has an h-index of 34, co-authored 91 publications.
Papers by this author
worksA phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
2011 · Kidney International · 251 citations
https://doi.org/10.1038/ki.2011.33
Isolation of two forms of basement membrane proteoglycans.
1985 · Journal of Biological Chemistry · 201 citations
https://doi.org/10.1016/s0021-9258(17)39569-8
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
2017 · Kidney International Reports · 130 citations
https://doi.org/10.1016/j.ekir.2017.03.011
Identification of the precursor protein to basement membrane heparan sulfate proteoglycans.
1985 · Journal of Biological Chemistry · 124 citations
https://doi.org/10.1016/s0021-9258(17)39570-4
Altered Steady-State mRNA Levels of Basement Membrane Proteins in Diabetic Mouse Kidneys and Thromboxane Synthase Inhibition
1990 · Diabetes · 113 citations
https://doi.org/10.2337/diab.39.2.196
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat